Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 1 33-1, 1996, Pages

  Halstead, Linda R ^b   Weinstein, Robert S ^b   Cheng, Su Li ^b   Rifas, Leonard ^b   Avioli, Louis V ^b  

^a BARNES JEWISH HOSPITAL   (United States)

^b NONE

Author keywords

1,25 dihydroxyvitamin D3; mouse; vitamin D resistant rickets

Indexed keywords

CALCITRIOL; OXYTETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METABOLISM; BONE MINERALIZATION; BONE TURNOVER; CALCIUM URINE LEVEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HYPERCALCEMIA; HYPOPHOSPHATEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VITAMIN D METABOLISM; VITAMIN D RESISTANT RICKETS; VITAMIN INTAKE;

EID: 0030050435     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.1.e141     Document Type: Article

References (30)

1. Alon, U., D. L. Donaldson, S. Hellerstein, B. A. Warady, and D. J. Harris. Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the hyp mouse. J. Pediatr. 120: 899-905, 1992.
2. Bell, C. L., H. S. Tenenhouse, and C. R. Scriver. Primary cultures of renal epithelial cells from X-linked hypophosphatemic (Hyp) mice express defects in phosphate transport and vitamin D metabolism. Am. J. Hum. Genet. 43: 293-303, 1988.
3. Brown, A. J., A. Dusso, and E. Slatopolsky. Selective vitamin D analogs and their therapeutic applications. Semin. Nephrol. 14: 156-174, 1994.
4. Brown, A. J., J. L. Finch, M. Grieff, C. Ritter, N. Kubodera, Y. Nishii, and E. Slatopolsky. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Endocrinology 133: 1158-1164, 1993.
5. Chen, P. S., T. Y. Toribara, and H. Warner. Microdetermination of phosphorus. Anal. Chem. 28: 1756-1758, 1956.
6. Cowgill, L. D., S. Goldfarb, K. Lau, and E. Slatopolsky. Evidence for an intrinsic renal tubular defect in mice with genetic hypophosphatemic rickets. J. Clin. Invent. 63: 1203-1210, 1979.
7. 3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. J. Clin. Invest. 66: 1020-1026, 1980.
8. Eicher, E. M., J. L. Southard, C. R. Scriver, and F. H. Glorieux. Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin-D resistant) rickets. Proc. Natl. Acad. Sci. USA 73: 4667-4671, 1976.
9. 3 and 22-oxacalcitriol on phosphate and calcium metabolism. Kidney Int. 43: 561-566, 1993.
10. Giaconelli, F., D. Spiro, and J. Weiner. A study of metastatic renal calcification at the cellular level. J. Cell Biol. 22: 189-206, 1964.
11. Ham, A. W., and M. D. Lewis. Hypervitaminosis D rickets. The action of vitamin D. Br. J. Exp. Pathol. 15: 228-234, 1934.
12. Hardy, D. C., W. A. Murphy, B. A. Siegel, I. R. Reid, and M. P. Whyte. X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology 171: 403-414, 1989.
13. Harris, L. J., and J. R. M. Innes. The mode of action of vitamin D. Studies on hypervitaminosis D. The influence of the calcium-phosphate intake. Biochem. J. 25: 367-390, 1931.
14. + gradient, membrane potential, and pH. J. Bone Miner. Res. 7: 563-571, 1992.
15. 3 in long bones of rats. Calcif. Tissue Int. 38: 79-86, 1986.
16. 3 in the young X-linked hypophosphatemic mouse. Endocrinology 111: 904-911, 1982.
17. Marie, P. J., R. Travers, and F. H. Glorieux. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif. Tissue Int. 34: 158-64, 1982.
18. Meyer, R. A., Jr., J. Jowsey, and M. H. Meyer. Osteomalacia and altered magnesium metabolism in the X-linked hypophosphatemic mouse. Calcif. Tissue Int. 27: 19-26, 1979.
19. 3 and 22-oxa-calcitriol on skeletal growth in X-linked hypophosphatemic (Hyp) mice. Ann. Orthopaedic Res. Soc. Meet. 40th 1994, p. 340.
20. Meyer, R. A., Jr., M. H. Meyer, and R. W. Gray. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J. Bone Miner. Res. 4: 493-500, 1989.
21. 3 analogues. Chem. Pharm. Bull. Tokyo 34: 4410-4413, 1987.
22. +-phosphate transporter in vitamin D-resistant hypophosphatemic mice. J. Biol. Chem. 266: 13616-13620, 1991.
23. Naveh-Many, T., and J. Silver. Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression. Endocrinology 133: 2724-2728, 1993.
24. Nesbitt, T., T. M. Coffman, R. Griffiths, and M. K. Drezner. Cross-transplantation of kidneys in normal and Hyp/Y mice. J. Clin. Invest. 89: 1453-1459, 1992.
25. Petersen, D. J., A. M. Boniface, F. W. Schranck, R. C. Rupich, and M. P. Whyte. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy. J. Bone Miner. Res. 7: 583-597, 1992.
26. Rasmussen, H., and C. Anast. Familial hypophosphatemic rickets and vitamin D-dependent rickets. In: The Metabolic Basis of Inherited Diseases (5th ed.), edited by J. B. Stanbury, J. B. Wyngaarden, D. S. Frederickson, J. L. Goldstein, and M. S. Brown. New York: McGraw-Hill, 1983, p. 1743-1773.
27. Rifas, L., L. L. Dawson, L. R. Halstead, M. Roberts, and L. V. Avioli. Phosphate transport in osteoblasts from normal and X-linked hypophosphatemie mice. Calcif. Tissue Int. 54: 505-511, 1994.
28. 3 on phosphate homeostases in the X-linked hypophosphatemic (Hyp) mouse. Endocrinology 109: 658-666, 1981.
29. Verge, C. F., A. Lam, J. M. Simpson, C. T. Cowell, N. J. Howard, and M. Silink. Effect of therapy in X-linked hypophosphatemic rickets. N. Engl. J. Med. 325: 1843-1848, 1991.
30. Weinstein, R. S., and N. H. Bell. Diminished rates of bone formation in normal black adults. N. Engl. J. Med. 319: 1698-1701, 1988.